We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Cardinal Health, Inc. (NYSE:CAH) is one of the stocks Jim Cramer recently discussed.
Cardinal Health, Inc. (NYSE:CAH) is an American healthcare company whose shares have gained 25.5% year-to-date. However, the stock would have been higher had it not been for a 7.2% dip in August. Cardinal Health, Inc. (NYSE:CAH)’s shares fell after the firm missed fourth quarter analyst revenue estimates. Cramer discussed the earnings:
“[On guidance raise] Oh my god. I wanted to holler the Hollar. The Hollar was good. I’ve had Hollar on the show many times. He’s the CEO. And holy cow, they didn’t do the number. They didn’t do the number. This man is like, same thing like a McKesson. . .except for they added a lot of high value added things. And it’s not working. That was a tremendous blow. I had that one nailed as being something that would have a good quarter. Thank heavens I didn’t put money on it for my trust. Wow. That is something. David, that is something.
“Jason Hollar has reinvented that company, and I’ve had him on and he’s, by the way, not [inaudible] does he ever miss numbers, but he’s blown away the numbers time and time again. This was not a blow away. I was very surprised.”
The CNBC TV host was quite optimistic about Cardinal Health, Inc. (NYSE:CAH) earlier. Here is what he said:
“Carl, one of the companies that has been unbelievable is Cardinal Health. They’ve been saying look we’re not just the middleman, not just the McKesson doing badly or Cencora. But this company, uniquely, Jason Hollar is making it into a very important healthcare company. And I think on June 12th, when they do the analyst conference, wow, you’re going to love it. You should love it today ahead of the analyst conference. It’s going to be unbelievable.”
While we acknowledge the potential of CAH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.